Search Results for 'sof genotype'

sof genotype published presentations and documents on DocSlides.

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

by pasty-toler

ASTRAL-1. Phase 3. . Treatment. . Naïve & ...

by lois-ondreau

400/100 mg . qd. N = 500. N = 100. W12. Placebo. ...

SMV 150 mg QD SOF 400 mg QD

SMV 150 mg QD SOF 400 mg QD

by alida-meadow

Randomisation. 1 : 1. 18-70 years. HCV genotype 1...

Sofosbuvir-Velpatasvir in Genotype 2

Sofosbuvir-Velpatasvir in Genotype 2

by stefany-barnette

ASTRAL-2*. Phase 3. . Treatment. . Naïve &...

C-SWIFT Study: elbasvir/grazoprevir + SOF

C-SWIFT Study: elbasvir/grazoprevir + SOF

by pamella-moone

in genotypes 1 or 3, with or without cirrhosis. &...

by celsa-spraggs

400/100/100 mg QD. N = 501. N = 440. W8. SOF/VEL ...

C-SWIFT Study: elbasvir/grazoprevir + SOF

C-SWIFT Study: elbasvir/grazoprevir + SOF

by myesha-ticknor

in genotypes 1 or 3, with or without cirrhosis. &...

Hepatitis C Drug Pipeline

Hepatitis C Drug Pipeline

by cheryl-pisano

HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...

by faustina-dinatale

qd. + SOF 400 mg . qd. N = 40. W12. 18-70 years....

LDV/SOF 90/400 mg

LDV/SOF 90/400 mg

by aaron

qd. Non-randomised. Open-label. N =. 21. W12. SV...

FISSION Design Objective

FISSION Design Objective

by travis

Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...

Are Pan-Genotypic Therapies Ready for Prime Time?

Are Pan-Genotypic Therapies Ready for Prime Time?

by lois-ondreau

3. Rd. International . HIV/Hepatitis . Coinfecti...

Virological characterization of patients with CHC and failure to a

Virological characterization of patients with CHC and failure to a

by isabella2

glecaprevir. /. pibrentasvir. or . voxilaprevir. ...

NIAID ERADICATE

NIAID ERADICATE

by tatiana-dople

Open-label. W12. ≥ 18 years. Chronic HCV infect...

SMV + DCV + SOF Open label

SMV + DCV + SOF Open label

by summer

≥ 18 years. Chronic HCV infection. Genotype 1 or...

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

by danika-pritchard

NIAID Retreatment. Phase . 2a . Treatment. . Exp...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by trish-goza

in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...

by pamella-moone

400/100/100 mg QD. N = 263. N = 152. W12. Placebo...

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

Sofosbuvir + Peginterferon + Ribavirin in Genotype 2

by debby-jeon

. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...

by debby-jeon

SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....

by conchita-marotz

Open-label. Chronic HCV infection. Genotype 1 . F...

Sofosbuvir in Genotypes 2 or 3

Sofosbuvir in Genotypes 2 or 3

by giovanna-bartolotta

VALENCE Trial. Phase . 3. Treatment. Naïve and ...

Sofosbuvir + Ribavirin in HCV Genotype 1

Sofosbuvir + Ribavirin in HCV Genotype 1

by pamella-moone

NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...

by giovanna-bartolotta

Genotype . 2. . or 3 . FUSION. Trial. Phase . ...

Sofosbuvir-Velpatasvir

Sofosbuvir-Velpatasvir

by jane-oiler

(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...

by trish-goza

400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...

by celsa-spraggs

N = 69. >. 18 years. Failure to SOF/VEL . or ...

ALLY-3 Design Objective SVR

ALLY-3 Design Objective SVR

by mitsue-stanley

12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...

SOF/VEL + GS-9857 N = 33

SOF/VEL + GS-9857 N = 33

by taylor291

>. 18 years. Genotype 2, 3, 4, 5 or 6. HCV RNA...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

by kittie-lecroy

Interim Analysis of a French Multicenter Compassi...

by sherrill-nordquist

SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...

by trish-goza

+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...

by tawny-fly

Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...

by giovanna-bartolotta

+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...

Sofosbuvir in Genotypes 2 or 3

Sofosbuvir in Genotypes 2 or 3

by kittie-lecroy

VALENCE Trial Phase 3 Treatment Na

Principal components analysis

Principal components analysis

by kittie-lecroy

Gavin Band. Why do PCA?. PCA is good at detecting...

Randomisation 2 : 1 Open-label

Randomisation 2 : 1 Open-label

by stefany-barnette

≥ 18 years. HCV genotype 3. Treatment-naïve ....

Hepatitis C Imtiaz Alam, M.D.

Hepatitis C Imtiaz Alam, M.D.

by olivia-moreira

Medical Director, Austin Hepatitis Center. 1. Hep...

Design Sofosbuvir / velpatasvir

Design Sofosbuvir / velpatasvir

by fullyshro

for 12 weeks in liver transplant recipients with g...

THALASSEMIA Dr. M. A. SOFI

THALASSEMIA Dr. M. A. SOFI

by clara

MD; FRCP (London); . FRCPEdin. ; . FRCSEdin. T. ha...